PAIGE VENABLES: Open Payments
NPI 1912410119 · MILFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,934 in 77 payments from 17 companies in 2025. Trend: 2023 $2,984 · 2024 $2,134 · 2025 $1,934
Food & beverage: $1,735Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $425 |
| UCB, Inc. | 8 | $231 |
| GENZYME CORPORATION | 6 | $205 |
| Novartis Pharmaceuticals Corporation | 7 | $164 |
| E.R. Squibb & Sons, L.L.C. | 7 | $162 |
| ABBVIE INC. | 9 | $141 |
| Lilly USA, LLC | 8 | $126 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Eli Lilly and Company | 1 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $87 |
Products named: TREMFYA, DUPIXENT, Bimzelx, Sotyktu, SKYRIZI, TALTZ, ILUMYA, COSENTYX.
Industry payments across DE — which companies pay providers there.
